Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Role of PLA2R and Anti-PLA2R in Idiopathic Membranous Nephropathy | Grant |
Why?
|
| Does Epitope Spreading Influence Responsiveness to Rituximab in PLA2R-Associated Membranous Nephropathy? | Academic Article |
Why?
|
| Refining Our Understanding of the PLA2R-Antibody Response in Primary Membranous Nephropathy: Looking Forward, Looking Back. | Academic Article |
Why?
|
| Detection and monitoring PLA2R autoantibodies by LIPS in membranous nephropathy. | Academic Article |
Why?
|
| Membranous nephropathy: diagnosis, treatment, and monitoring in the post-PLA2R era. | Academic Article |
Why?
|
| Monoclonal anti-PLA2R and recurrent membranous nephropathy: another piece of the puzzle. | Academic Article |
Why?
|
| PLA2R and THSD7A: Disparate Paths to the Same Disease? | Academic Article |
Why?
|
| Pregnancy in a Patient With Primary Membranous Nephropathy and Circulating Anti-PLA2R Antibodies: A Case Report. | Academic Article |
Why?
|
| Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. | Academic Article |
Why?
|
| Towards optimizing use of PLA2R antibody testing in membranous nephropathy. | Academic Article |
Why?
|
| Anti-PLA2R Immunoreactivity | Grant |
Why?
|
| Investigation of Anti-PLA2R-Associated Membranous Nephropathy at the Molecular Level | Grant |
Why?
|
| Podocyte-specific human PLA2R transgenic mouse model of membranous nephropathy | Grant |
Why?
|
| The latest model has just arrived! A new experimental mouse model of PLA2R1-associated membranous nephropathy. | Academic Article |
Why?
|
| Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. | Academic Article |
Why?
|